IDEXX LABORATORIES INC /DE Quarterly Contract with Customer, Liability, Current in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Idexx Laboratories Inc /De quarterly Contract with Customer, Liability, Current history and growth rate from Q4 2017 to Q3 2024.
  • Idexx Laboratories Inc /De Contract with Customer, Liability, Current for the quarter ending September 30, 2024 was $38.4M, a 3.09% increase year-over-year.
Contract with Customer, Liability, Current, Quarterly (USD)
Contract with Customer, Liability, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $38.4M +$1.15M +3.09% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $38M +$219K +0.58% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $38.2M +$354K +0.94% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $37.2M -$743K -1.96% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $37.3M -$3.53M -8.64% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $37.8M -$3M -7.35% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $37.8M -$3.07M -7.5% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $37.9M -$2.1M -5.24% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $40.8M -$319K -0.78% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $40.8M -$355K -0.86% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $40.9M -$734K -1.76% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $40M -$2.53M -5.95% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $41.1M -$1.47M -3.45% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $41.1M +$4.81M +13.3% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $41.6M +$3.61M +9.5% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $42.6M +$1.11M +2.67% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $42.6M -$387K -0.9% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $36.3M -$7.13M -16.4% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $38M -$5.32M -12.3% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $41.5M +$172K +0.42% Dec 31, 2019 10-K 2021-02-12
Q3 2019 $43M +$1.84M +4.46% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $43.4M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $43.4M Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $41.3M +$12.1M +41.5% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $41.1M Sep 30, 2018 10-Q 2018-11-01
Q4 2017 $29.2M Dec 31, 2017 10-K 2019-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.